These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27194508)

  • 1. NMR Fragment Screening Hit Induces Plasticity of BRD7/9 Bromodomains.
    Wang N; Li F; Bao H; Li J; Wu J; Ruan K
    Chembiochem; 2016 Aug; 17(15):1456-63. PubMed ID: 27194508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of chemical probes for the bromodomains of BRD7 and BRD9.
    Clark PG; Dixon DJ; Brennan PE
    Drug Discov Today Technol; 2016 Mar; 19():73-80. PubMed ID: 27769361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Basis of Inhibitor Selectivity in the BRD7/9 Subfamily of Bromodomains.
    Karim RM; Chan A; Zhu JY; Schönbrunn E
    J Med Chem; 2020 Mar; 63(6):3227-3237. PubMed ID: 32091206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer.
    Ordonez-Rubiano SC; Maschinot CA; Wang S; Sood S; Baracaldo-Lancheros LF; Strohmier BP; McQuade AJ; Smith BC; Dykhuizen EC
    J Med Chem; 2023 Aug; 66(16):11250-11270. PubMed ID: 37552884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Atypical Acetyl-lysine Methyl Mimetics in the Development of Selective Inhibitors of the Bromodomain-Containing Protein 7 (BRD7)/Bromodomain-Containing Protein 9 (BRD9) Bromodomains.
    Clegg MA; Bamborough P; Chung CW; Craggs PD; Gordon L; Grandi P; Leveridge M; Lindon M; Liwicki GM; Michon AM; Molnar J; Rioja I; Soden PE; Theodoulou NH; Werner T; Tomkinson NCO; Prinjha RK; Humphreys PG
    J Med Chem; 2020 Jun; 63(11):5816-5840. PubMed ID: 32410449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.
    Clark PG; Vieira LC; Tallant C; Fedorov O; Singleton DC; Rogers CM; Monteiro OP; Bennett JM; Baronio R; Müller S; Daniels DL; Méndez J; Knapp S; Brennan PE; Dixon DJ
    Angew Chem Int Ed Engl; 2015 May; 54(21):6217-21. PubMed ID: 25864491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Subset of Human Bromodomains Recognizes Butyryllysine and Crotonyllysine Histone Peptide Modifications.
    Flynn EM; Huang OW; Poy F; Oppikofer M; Bellon SF; Tang Y; Cochran AG
    Structure; 2015 Oct; 23(10):1801-1814. PubMed ID: 26365797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.
    Theodoulou NH; Bamborough P; Bannister AJ; Becher I; Bit RA; Che KH; Chung CW; Dittmann A; Drewes G; Drewry DH; Gordon L; Grandi P; Leveridge M; Lindon M; Michon AM; Molnar J; Robson SC; Tomkinson NC; Kouzarides T; Prinjha RK; Humphreys PG
    J Med Chem; 2016 Feb; 59(4):1425-39. PubMed ID: 25856009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bromodomains of BET family proteins can recognize diacetylated histone H2A.Z.
    Patel K; Solomon PD; Walshe JL; Low JKK; Mackay JP
    Protein Sci; 2021 Feb; 30(2):464-476. PubMed ID: 33247496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Acyl Pyrroles as Dual BET-BRD7/9 Bromodomain Inhibitors Address BETi Insensitive Human Cancer Cell Lines.
    Hügle M; Regenass P; Warstat R; Hau M; Schmidtkunz K; Lucas X; Wohlwend D; Einsle O; Jung M; Breit B; Günther S
    J Med Chem; 2020 Dec; 63(24):15603-15620. PubMed ID: 33275431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.
    Fish PV; Filippakopoulos P; Bish G; Brennan PE; Bunnage ME; Cook AS; Federov O; Gerstenberger BS; Jones H; Knapp S; Marsden B; Nocka K; Owen DR; Philpott M; Picaud S; Primiano MJ; Ralph MJ; Sciammetta N; Trzupek JD
    J Med Chem; 2012 Nov; 55(22):9831-7. PubMed ID: 23095041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in the Development of non-BET Bromodomain Chemical Probes.
    Theodoulou NH; Tomkinson NC; Prinjha RK; Humphreys PG
    ChemMedChem; 2016 Mar; 11(5):477-87. PubMed ID: 26749027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.
    Sun H; Liu J; Zhang J; Shen W; Huang H; Xu C; Dai H; Wu J; Shi Y
    Biochem Biophys Res Commun; 2007 Jun; 358(2):435-41. PubMed ID: 17498659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical Proteomic Profiling of Bromodomains Enables the Wide-Spectrum Evaluation of Bromodomain Inhibitors in Living Cells.
    Li X; Wu Y; Tian G; Jiang Y; Liu Z; Meng X; Bao X; Feng L; Sun H; Deng H; Li XD
    J Am Chem Soc; 2019 Jul; 141(29):11497-11505. PubMed ID: 31246451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.
    Chen P; Chaikuad A; Bamborough P; Bantscheff M; Bountra C; Chung CW; Fedorov O; Grandi P; Jung D; Lesniak R; Lindon M; Müller S; Philpott M; Prinjha R; Rogers C; Selenski C; Tallant C; Werner T; Willson TM; Knapp S; Drewry DH
    J Med Chem; 2016 Feb; 59(4):1410-24. PubMed ID: 25799074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.
    Clark PG; Vieira LC; Tallant C; Fedorov O; Singleton DC; Rogers CM; Monteiro OP; Bennett JM; Baronio R; Müller S; Daniels DL; Méndez J; Knapp S; Brennan PE; Dixon DJ
    Angew Chem Weinheim Bergstr Ger; 2015 May; 127(21):6315-6319. PubMed ID: 27346896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancements in the Development of non-BET Bromodomain Chemical Probes.
    Clegg MA; Tomkinson NCO; Prinjha RK; Humphreys PG
    ChemMedChem; 2019 Feb; 14(4):362-385. PubMed ID: 30624862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands.
    Remillard D; Buckley DL; Paulk J; Brien GL; Sonnett M; Seo HS; Dastjerdi S; Wühr M; Dhe-Paganon S; Armstrong SA; Bradner JE
    Angew Chem Int Ed Engl; 2017 May; 56(21):5738-5743. PubMed ID: 28418626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
    Kharenko OA; Gesner EM; Patel RG; Norek K; White A; Fontano E; Suto RK; Young PR; McLure KG; Hansen HC
    Biochem Biophys Res Commun; 2016 Aug; 477(1):62-67. PubMed ID: 27282480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.
    Peng C; Zhou J; Liu HY; Zhou M; Wang LL; Zhang QH; Yang YX; Xiong W; Shen SR; Li XL; Li GY
    J Cell Biochem; 2006 Mar; 97(4):882-92. PubMed ID: 16265664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.